Diagnostic testing fails the test.
作者信息
Merz Jon F, Kriss Antigone G, Leonard Debra G B, Cho Mildred K
机构信息
Center for Bioethics, University of Pennsylvania, Philadelphia, Pennsylvania 19104-3308, USA.
出版信息
Nature. 2002 Feb 7;415(6872):577-9. doi: 10.1038/415577a.
Abstract
摘要
相似文献
1
Diagnostic testing fails the test.诊断测试未通过测试。
Nature. 2002 Feb 7;415(6872):577-9. doi: 10.1038/415577a.
2
Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis.基因专利和许可实践对遗传性血色素沉着症遗传检测可及性的影响。
Genet Med. 2010 Apr;12(4 Suppl):S155-70. doi: 10.1097/GIM.0b013e3181d7acb0.
3
Will genetics revolutionize medicine?基因学将给医学带来革命性变化吗？
N Engl J Med. 2000 Nov 16;343(20):1496; discussion 1498.
4
Screening for hemochromatosis. A public health perspective.
Am J Prev Med. 1999 Feb;16(2):134-40. doi: 10.1016/s0749-3797(98)00141-x.
5
American College of Medical Genetics position statement on gene patents and accessibility of gene testing.美国医学遗传学学会关于基因专利和基因检测可及性的立场声明。
Genet Med. 1999 Jul-Aug;1(5):237. doi: 10.1097/00125817-199907000-00013.
6
Genetic testing for hemochromatosis: attitudes and acceptability among young and older adults.血色素沉着症的基因检测：年轻人和老年人的态度及可接受性
Genet Test. 2003 Fall;7(3):235-9. doi: 10.1089/109065703322537250.
7
Clinical guidelines: HFE hemochromatosis-screening, diagnosis and management.临床指南：HFE 遗传性血色素沉着症的筛查、诊断与管理
Nat Rev Gastroenterol Hepatol. 2010 Sep;7(9):482-4. doi: 10.1038/nrgastro.2010.132.
8
Insurance agreement to facilitate genetic testing.
Lancet. 2002 Apr 20;359(9315):1433. doi: 10.1016/S0140-6736(02)08369-1.
9
Genetics in practice: 1. Hereditary hemochromatosis.遗传学实际应用：1. 遗传性血色素沉着症。
Hosp Pract (1995). 2000 May 15;35(5):101-4. doi: 10.1080/21548331.2000.11444024.
10
[Diagnostic strategies in inherited hemochromatosis. Value of the genetic test].[遗传性血色素沉着症的诊断策略。基因检测的价值]
Rev Clin Esp. 2000 Sep;200(9):516-9. doi: 10.1016/s0014-2565(00)70706-5.
引用本文的文献
1
Continental drift? Do European clinical genetic testing laboratories have a patent problem?大陆漂移？欧洲临床遗传检测实验室有专利问题吗？
Eur J Hum Genet. 2019 Jul;27(7):997-1007. doi: 10.1038/s41431-019-0368-7. Epub 2019 Mar 7.
2
Ethics and Quality Assessment in Genetic Testing.基因检测中的伦理与质量评估
EJIFCC. 2005 May 17;16(2):73-76. eCollection 2005 May.
3
Gene patenting--the Supreme Court finally speaks.基因专利——最高法院终于表态了。
N Engl J Med. 2013 Aug 29;369(9):869-75. doi: 10.1056/NEJMhle1308199. Epub 2013 Jul 10.
4
Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.基因专利与个体化癌症治疗：Myriad 案对临床肿瘤学的影响。
J Clin Oncol. 2013 Jul 20;31(21):2743-8. doi: 10.1200/JCO.2013.49.7388. Epub 2013 Jun 13.
5
Commercial landscape of noninvasive prenatal testing in the United States.美国无创性产前检测的商业景观。
Prenat Diagn. 2013 Jun;33(6):521-31. doi: 10.1002/pd.4101.
6
Harm, hype and evidence: ELSI research and policy guidance.危害、炒作与证据：ELSI 研究与政策指导。
Genome Med. 2013 Mar 26;5(3):21. doi: 10.1186/gm425. eCollection 2013.
7
It's about scientific secrecy, dummy: a better equilibrium among genomics patenting, scientific research and health care.这是关于科学保密的问题，蠢货：在基因组专利、科学研究和医疗保健之间取得更好的平衡。
Sci Eng Ethics. 2012 Jun;18(2):263-84. doi: 10.1007/s11948-011-9257-3. Epub 2011 Feb 13.
8
The impact of human gene patents on genetic testing in the United Kingdom.人类基因专利对英国基因检测的影响。
Genet Med. 2011 Apr;13(4):320-4. doi: 10.1097/GIM.0b013e3181fc50bc.
9
Patently unpatentable: implications of the Myriad court decision on genetic diagnostics.明显不可专利：Myriad 法院判决对基因诊断学的影响。
Trends Biotechnol. 2010 Nov;28(11):548-51. doi: 10.1016/j.tibtech.2010.08.005.
10
DNA patents and diagnostics: not a pretty picture.DNA专利与诊断：情况不妙。
Nat Biotechnol. 2010 Aug;28(8):784-91. doi: 10.1038/nbt0810-784.
本文引用的文献
1
Testing time for gene patent as Europe rebels.随着欧洲的反对，基因专利面临考验时刻。
Nature. 2001 Oct 4;413(6855):443. doi: 10.1038/35097228.
2
What's new in hemochromatosis.血色素沉着症的新进展。
Curr Opin Hematol. 2001 Mar;8(2):98-104. doi: 10.1097/00062752-200103000-00007.
3
Detection of an unusual combination of mutations in the HFE gene for hemochromatosis.血色素沉着症HFE基因突变异常组合的检测。
Genet Test. 2000;4(4):371-6. doi: 10.1089/109065700750065117.
4
Uncommon mutations and polymorphisms in the hemochromatosis gene.
Genet Test. 2000;4(2):151-61. doi: 10.1089/10906570050114867.
5
Survey confirms fears about licensing of genetic tests.
Nature. 1999 Nov 11;402(6758):118. doi: 10.1038/45907.
6
Disease gene patents: overcoming unethical constraints on clinical laboratory medicine.疾病基因专利：克服临床检验医学中的不道德限制。
Clin Chem. 1999 Mar;45(3):324-30.
7
Can patents deter innovation? The anticommons in biomedical research.专利会阻碍创新吗？生物医学研究中的反公地悲剧。
Science. 1998 May 1;280(5364):698-701. doi: 10.1126/science.280.5364.698.
8
Public-sector patents on human DNA.
Nature. 1997 Aug 21;388(6644):709. doi: 10.1038/41853.
9
Withholding research results in academic life science. Evidence from a national survey of faculty.学术生命科学领域研究成果的隐瞒。来自一项针对教师的全国性调查的证据。
JAMA. 1997 Apr 16;277(15):1224-8.
10
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.一种新的MHC I类样基因在遗传性血色素沉着症患者中发生突变。
Nat Genet. 1996 Aug;13(4):399-408. doi: 10.1038/ng0896-399.
Zotero 插件